2013年10月2日アボット ジャパン株式会社（本社：東京都港区、代表取締役会長兼社長 坂本春喜）は、血糖と血中β－ケトンの両方を測定できる院内用の測定器「フリースタイルプレシジョンプロ」 （FreeStyle Precision Pro）を本日発売しました。 「フリース ...

配信日時: 2013-10-02 11:00:00 ―ホイル包装の電極で感染リスクを軽減 ― ― 測定時間を5秒に大幅短縮 ― 2013年10月2日 アボット ジャパン株式会社（本社：東京都港区、代表取締役会長兼社長 坂本春喜）は、血糖と血中β－ケトンの両方を測定できる院内用の測定 ...

ABBOTT PARK, Ill., July 25, 2013 /PRNewswire/ -- Abbott (NYSE: ABT)today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its FreeStyle Precision Pro Blood Glucose ...

Abbott (NYSE: ABT) today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System™, an advanced ...

Only inpatient blood glucose monitoring system among leading hospital brands to use individually foil-wrapped test strips, helping reduce risk of test strip cross-contamination ABBOTT PARK, Ill., July ...

Abbott has received clearance from the FDA for the FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System, a blood glucose monitoring system designed to address the needs of ...

Abbott Laboratories ($ABT) picked up FDA clearance to market the FreeStyle Precision Pro, an inpatient blood glucose monitor the company said can stream test results ...